In recent years, evidence for an enrichment of antigen-experienced CD8+ T-cells in CLL has accumulated, and these cells have been shown to control leukemia in a CLL mouse model. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.